- Home
- FHN vs CRL Comparison
FHN vs CRL Comparison
Compare FHN & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- CRL
- Stock Information
- Founded
- FHN 1864
- CRL 1947
- Country
- FHN United States
- CRL United States
- Employees
- FHN N/A
- CRL N/A
- Industry
- FHN Major Banks
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FHN Finance
- CRL Health Care
- Exchange
- FHN Nasdaq
- CRL Nasdaq
- Market Cap
- FHN 10.4B
- CRL 9.8B
- IPO Year
- FHN N/A
- CRL 2000
- Fundamental
- Price
- FHN $20.04
- CRL $189.82
- Analyst Decision
- FHN Buy
- CRL Hold
- Analyst Count
- FHN 14
- CRL 13
- Target Price
- FHN $20.00
- CRL $211.64
- AVG Volume (30 Days)
- FHN 5.3M
- CRL 506.6K
- Earning Date
- FHN 01-16-2025
- CRL 02-12-2025
- Dividend Yield
- FHN 3.02%
- CRL N/A
- EPS Growth
- FHN N/A
- CRL N/A
- EPS
- FHN 1.37
- CRL 8.00
- Revenue
- FHN $3,071,000,000.00
- CRL $4,060,916,000.00
- Revenue This Year
- FHN N/A
- CRL N/A
- Revenue Next Year
- FHN $2.14
- CRL $1.57
- P/E Ratio
- FHN $14.52
- CRL $23.72
- Revenue Growth
- FHN 0.03
- CRL N/A
- 52 Week Low
- FHN $12.95
- CRL $176.48
- 52 Week High
- FHN $21.72
- CRL $275.00
- Technical
- Relative Strength Index (RSI)
- FHN 49.87
- CRL 43.48
- Support Level
- FHN $19.75
- CRL $188.56
- Resistance Level
- FHN $20.88
- CRL $199.45
- Average True Range (ATR)
- FHN 0.40
- CRL 5.60
- MACD
- FHN -0.20
- CRL -1.02
- Stochastic Oscillator
- FHN 15.61
- CRL 6.83
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The regional bank is responsible for roughly 65% of its revenue, while capital markets make a 25% contribution. The remainder is split between the firm's non-strategic (wind-down) and corporate operations. First Horizon concentrates on offering a variety of banking products mainly in its home state, where it has the second- largest deposit franchise with a 13% deposit market share.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.